Search Results 81-90 of 22977 for Phase
The phase 1 trial involved nine study participants with radiographically confirmed knee OA. The nine participants were divided into three dosage groups (low, ...
A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases · Overview · Participation eligibility · Participating Mayo Clinic ...
The purpose of Phase Ib is to evaluate the safety and tolerability of the combination of TG4001 plus avelumab in patients with recurrent or metastatic HPV-16 ...
About this study. A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment ...
Part 2 is a long-term treatment phase in which all participants receive open-label vimseltinib. Participation eligibility. Participant eligibility includes age, ...
The overall objective of this Phase III clinical trial is to obtain information from a population of 500 ICH subjects with intraventricular hemorrhage (IVH), ...
Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer · More about research at Mayo ...
The purpose of this study is to evaluate safety and efficacy of VGT-309 to identify cancer in up to 40 subjects undergoing lung cancer surgery. Participation ...
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma · Overview.
A Phase I study of Epalrestat Therapy in a Single Patient with Phosphomannomutase Deficiency (PMM2-CDG). Print details. Share; Facebook · Twitter.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.